cathepsin
synthes
preproenzym
wherebi
signal
peptid
target
entri
nascent
chain
lumen
rough
endoplasm
reticulum
rer
signal
peptid
pre
cotransl
cleav
signal
peptidas
upon
entri
er
lumen
propeptid
pro
keep
procathepsin
zymogen
form
proteolyt
inact
transport
rer
via
golgi
apparatu
transgolgi
network
tgn
late
endosom
fig
brix
et
al
erickson
et
al
procathepsin
need
pass
qualiti
control
rer
becom
posttransl
modifi
travel
tgn
interestingli
proper
fold
cathepsin
convey
propeptid
bear
chaperon
function
import
beststudi
posttransl
modif
cathepsin
mannos
believ
occur
cisgolgi
requir
recognit
cationdepend
mannos
receptor
cdmpr
tgn
sort
zymogen
clathrinco
transport
vesicl
fig
de
duve
wattiaux
kornfeld
mellman
von
figura
kornfeld
erickson
et
al
brix
et
al
upon
arriv
late
endosom
ph
drop
procathepsin
dissoci
sort
cdmpr
recycl
back
tgn
via
retromerco
vesicl
late
endosom
procathepsin
proteolyt
process
acquir
matur
proteolyt
activ
state
fig
therefor
either
asparaginyl
endo
peptidas
aep
better
known
legumain
cathepsin
cleav
procathepsin
tran
propeptid
remov
matur
form
deliv
function
solubl
enzym
compart
endocyt
pathway
thu
proteolyt
process
matur
activ
procathepsin
take
place
late
endosom
indic
molecul
ar
architectur
cathepsin
featur
ntermin
signal
peptid
typic
follow
inhibitori
propeptid
peptidas
domain
tabl
howev
matur
singlechain
form
cathepsin
b
particular
process
therebi
yield
twochain
form
consist
light
heavi
chain
remain
bound
disulfid
bond
mort
buttl
singl
twochain
form
cathepsin
b
proteolyt
activ
hydrolas
molecular
architectur
procathepsinactiv
aeplegumain
differ
cathepsin
peptidas
domain
directli
follow
signal
peptid
prodomain
found
cterminu
tabl
legumain
except
act
peptidas
featur
also
peptid
lig
ase
activ
depend
condit
expos
dall
brandstett
cathepsin
belong
either
three
class
proteolyt
enzym
name
aspart
cystein
serin
proteas
rawl
rawl
et
al
henc
cathepsin
classifi
accord
amino
acid
activ
site
respons
catalyt
hydrolysi
peptid
bond
aspart
acid
cystein
residu
part
catalyt
dyad
aspart
cystein
cathepsin
respect
serin
part
catalyt
triad
addit
residu
requir
stabil
oxyanion
hole
acyl
intermedi
upon
interact
enzym
substrat
aspart
cathepsin
act
water
nucleophil
wherea
cystein
serin
cathepsin
act
protein
nucleophil
baici
et
al
henc
nucleophil
provid
side
chain
amino
acid
activ
site
name
sulfhydryl
hydroxyl
group
either
cystein
serin
respect
cystein
serin
cathepsin
exampl
serin
bear
nucleophil
hydroxyl
group
serin
cathepsin
histidin
act
gener
base
addit
aspart
help
orient
imidazolium
ring
histidin
activ
serin
perform
nucleophil
attack
peptid
bond
substrat
wherebi
temporari
complex
enzym
substrat
form
ie
acyl
intermedi
break
rapidli
result
proton
gener
base
histidin
subsequ
hydrolysi
scissil
bond
occur
water
molecul
enter
reaction
mechan
peptid
bond
hydrolysi
catalyz
cathepsin
therefor
involv
two
substrat
protein
peptid
substrat
water
molecul
two
product
gener
na
meli
n
ctermin
peptid
product
cathepsin
act
endopeptidas
fig
howev
cystein
cathepsin
b
x
serin
cathepsin
legumain
also
act
carboxypeptidas
wherea
cystein
cathepsin
h
act
aminopeptidas
cystein
cathepsin
c
form
dimer
act
dipeptidyl
peptidas
fig
thu
cathepsin
mostli
act
peptid
protein
substrat
monom
dimer
even
multimer
therebi
eventu
alter
substrat
specif
see
also
proteolyt
activ
substrat
specif
typic
determin
recombin
enzym
prepar
welldefin
vitro
assay
accord
schechter
berger
nomenclatur
schechter
berger
amino
acid
next
scissil
bond
toward
nterminu
substrat
name
ctermin
amino
acid
next
scissil
bond
name
follow
amino
acid
substrat
refer
respect
substratebind
pocket
cathepsin
name
accordingli
respect
everi
peptidas
standard
assay
determin
activ
cathepsin
avail
synthet
substrat
preferenti
specif
cleav
enzym
standard
cathepsin
activ
assay
mainli
consid
peptid
cleavag
optim
condit
wherebi
reduc
environ
acid
slightli
acid
condit
endolysosom
consid
main
determin
reader
refer
handbook
proteolyt
enzym
barrett
merop
databas
wwwmeropssangeracuk
rawl
et
al
provid
comprehens
excel
compendium
proteas
substrat
inhibitor
uptod
inform
note
cathepsin
vari
substrat
specif
mani
exhibit
overlap
substrat
cleavag
preferen
ce
make
sometim
difficult
distinguish
cathepsin
activ
ambigu
substrat
specif
often
complic
specif
inhibit
addit
cathepsin
redundantli
express
brix
et
al
reiser
et
al
gansz
et
al
sloan
et
al
thu
cathepsin
upregul
take
function
relat
enzym
latter
elimin
gene
knockout
inhibit
pharmacolog
intervent
phenomenon
redund
regul
cathepsin
express
observ
especi
coval
irrevers
instead
transient
revers
inhibit
appli
cathepsin
activ
counterbalanc
endogen
inhibitor
tabl
aspart
cathepsin
e
mostli
detect
lysosom
inhibit
pepstatin
dean
natur
product
isol
sea
anemon
actinia
equina
equistatin
latter
inhibitor
interestingli
also
interact
cystein
peptidas
lenarc
et
al
lenarc
turk
includ
cystein
cathepsin
found
preferenti
endolysosom
also
frequent
extra
pericellular
locat
furthermor
aberr
altern
form
cystein
cathepsin
detect
cytosol
well
nuclear
mitochondri
matric
brix
et
al
cytosol
cystatin
b
also
known
stefin
b
machleidt
et
al
brzin
et
al
well
secret
cystatin
c
em
f
sn
barrett
sloan
et
al
turk
bode
alvarezfernandez
et
al
abrahamson
et
al
turk
et
al
zeeuwen
et
al
serv
endogen
inhibitor
cystein
cathepsin
addit
identifi
inhibitor
cystein
cathepsin
fritz
travi
cystein
cathep
in
principl
also
inhibit
serpin
crossclass
inhibitor
serin
proteas
silverman
et
al
like
cystatin
serpin
present
intra
extracellularli
serpin
reactiv
center
loop
serv
bait
attack
serin
proteas
upon
cleavag
remain
bound
coval
linkag
enzym
huntington
whisstock
et
al
numer
tool
avail
studi
cathepsin
specif
antibodi
use
immunostain
experi
subsequ
inspect
light
electron
microscopi
strategi
use
antibodi
detect
cathepsin
often
bear
specif
problem
weber
et
al
cathepsin
evolutionari
conserv
show
extens
sequenc
homolog
synthet
substrat
like
chromogen
fluorogen
peptid
avail
vitro
activ
assay
see
merop
databas
detail
likewis
cyto
histochem
approach
describ
employ
synthet
cathepsin
substrat
convert
product
less
diffus
readili
detect
mean
microscopi
spiess
et
al
brix
et
al
enzymographi
polyacrylamid
gel
anoth
mean
determin
multipl
cathepsin
activ
time
cell
tissu
lysat
chen
platt
platt
et
al
number
chimer
protein
consist
cathepsin
fluoresc
protein
gener
express
mammalian
cell
review
see
brix
et
al
arampatzid
et
al
tag
cathepsin
follow
regular
transport
pathway
like
endogen
enzym
naganawa
et
al
link
et
al
b
arampatzid
et
al
frizler
et
al
tamhan
et
al
tamhan
et
al
traffick
studi
live
cell
combin
coloc
experi
compartmentspecif
marker
use
spot
fulllength
ntermin
truncat
specif
form
cathepsin
see
move
cell
link
et
al
zwicki
et
al
et
al
mayer
et
al
intervent
either
perman
block
transient
interf
specif
transport
rout
appli
order
investig
distinct
enzym
traffick
varieti
eukaryot
cell
eleg
way
visual
cathepsin
activ
spot
quantit
manner
use
socal
activitybas
probe
abp
greenbaum
et
al
jessani
et
al
blum
et
al
blum
edgington
et
al
blai
et
al
zou
et
al
grzywa
sanman
bogyo
abp
consist
reactiv
function
group
socal
warhead
bind
target
proteas
linker
region
resembl
peptid
substrat
addit
tag
group
tag
group
typic
fluorogen
biotin
iodinat
moieti
also
chemic
engin
onto
abp
henc
famili
subfamili
cathepsin
function
address
becom
coval
tag
upon
cleavag
abp
linker
abp
avail
broadspectrum
probe
use
approach
proteolyt
activ
aspart
cystein
serin
cathepsin
addit
specif
abp
synthes
cleav
one
cathepsin
moreov
abp
propeptidemimick
featur
peptid
backbon
use
schaschk
et
al
diederich
et
al
highli
specif
abp
principl
abl
distinguish
even
close
relat
cathepsin
onetoon
bind
principl
abp
render
power
tool
quantifi
cathepsin
activ
say
abp
act
inhibitor
attack
cleav
substratelik
fashion
remain
bound
target
enzym
thu
form
irrevers
coval
complex
target
proteas
concept
abp
label
cathepsin
compar
suicid
inhibit
mechan
serpin
target
proteas
see
principl
specif
irrevers
bind
bear
advantag
render
abp
quantit
probe
allow
detect
matur
proteolyt
activ
cathepsin
howev
disadvantag
mani
abp
equal
intrins
name
act
proteas
inhibitor
may
eventu
lead
pharmacolog
knockdown
proteolyt
activ
appli
live
cell
sketch
label
option
visual
local
quantifi
cathepsin
combin
possibl
variat
baruch
et
al
blum
et
al
brix
jordan
blum
sadaghiani
et
al
brix
et
al
arampatzid
et
al
salpet
blum
experi
help
uncov
transport
pathway
follow
pro
matur
cathepsin
differ
eukaryot
cell
importantli
state
art
distinguish
proteolyt
activ
inact
cathepsin
moreov
becam
clear
everi
cell
type
may
use
cathepsin
strateg
distinct
way
support
specif
cell
function
brix
et
al
moham
sloan
sloan
et
al
weisssadan
et
al
henc
subcellular
locat
cathepsin
activ
detect
encompass
expect
canon
endolysosom
compart
howev
quit
often
locat
cathepsin
activ
detect
mean
unexpect
thu
cathepsin
exhibit
astonish
varieti
transport
pathway
reach
numer
intra
extracellular
locat
proteas
may
function
spatial
confin
tempor
regul
manner
moham
sloan
gocheva
joyc
brix
et
al
akkari
et
al
procathepsin
may
skip
recognit
cdmpr
tgn
becom
sort
transport
along
secretori
pathway
destin
cell
surfac
subsequ
secret
extracellular
space
fig
left
transport
rout
pericellularli
procathepsin
may
becom
activ
solubl
endopeptidas
action
plasma
membranebound
ectoenzym
yet
anoth
pathway
use
particular
cell
innat
immun
system
like
macrophag
express
cationindepend
mannos
receptor
cimpr
also
refer
mason
et
al
pohlmann
et
al
collett
et
al
cell
surfac
receptor
act
scaveng
receptor
function
rescu
faulti
excess
secret
procathepsin
subsequ
intern
endocytosi
sort
along
endocyt
pathway
henc
transport
extracellular
space
via
earli
endosom
late
endosom
fig
right
transport
rout
secret
form
cathepsin
eventu
activ
compart
follow
default
transport
pathway
delay
time
distinct
cell
type
featur
socal
secretori
lysosom
andrew
brix
et
al
endocyt
compart
resembl
late
endosom
lysosom
characterist
biochem
composit
henc
secretori
lysosom
cathepsin
recruit
within
late
endosom
lysosom
transport
retrograd
fashion
vesicl
fuse
plasma
membran
typic
upon
signal
altern
rout
cathepsin
transport
fig
bottom
right
transport
rout
observ
number
specif
cell
type
allow
secret
proteolyt
activ
cathepsin
extracellular
space
link
et
al
b
et
al
cathepsin
present
extracellular
space
matur
activ
enzym
inact
proform
procathepsin
underw
mannos
bind
cimpr
see
von
figura
erickson
et
al
brix
et
al
matur
cathepsin
procathepsin
also
becom
bound
arkona
wiederand
peloil
et
al
moreov
protein
serv
regul
number
proteas
name
inhibitor
matrix
metalloproteinas
cystein
cathepsin
alik
receptor
known
interact
secret
cathepsin
divers
lowdens
lipoprotein
ldl
receptorlik
protein
lrp
famili
transmembran
protein
present
cell
surfac
almost
cell
type
poller
et
al
willnow
et
al
herz
strickland
one
lrp
suppos
mediat
intern
endolysosom
deliveri
cathepsin
previous
secret
mistak
nielsen
et
al
thu
lrp
function
way
similar
cimpr
interact
also
pro
matur
cathepsin
lack
mannos
fig
right
transport
rout
pericellular
extra
cellular
local
procathepsin
matur
cathepsin
observ
physiolog
patholog
condit
instanc
cathepsinmedi
extracellular
proteolysi
shown
promot
cancer
cell
invas
tumor
progress
extracellular
matrix
ecm
degrad
rochefort
et
al
joyc
hanahan
liaudetcoopman
et
al
moham
sloan
gocheva
joyc
sloan
et
al
remain
seen
howev
enhanc
cathepsin
secret
respons
excess
ecm
degrad
trigger
acid
environ
tumor
tissu
mechan
cavallomedv
sloan
depend
extracellular
condit
cathepsin
may
acquir
alter
addit
substrat
prefer
exampl
cystein
cathepsin
k
secret
physiolog
condit
activ
enzym
act
acid
resorpt
lacuna
form
osteoclast
bone
turnov
gelb
et
al
saftig
et
al
rachner
et
al
turk
et
al
howev
cathepsin
k
also
respons
degrad
thyroglobulin
extracellular
thyroid
follicl
lumen
name
neutral
ph
oxid
condit
tepel
et
al
friedrich
et
al
jordan
et
al
moreov
secret
cathepsin
k
monom
interact
therebi
form
polymer
ringlik
structur
depend
molecular
composit
extracellular
space
li
et
al
shown
ecm
compon
like
glycosaminoglycan
constitu
essenti
scaffold
factor
support
extracellular
interact
cathepsin
k
molecul
li
et
al
moreov
cathepsin
k
stabil
extracellularli
bind
cell
surfac
molecul
like
clusterin
novinec
et
al
also
interact
proteas
receptor
lrp
famili
eg
lemanski
et
al
importantli
activ
particular
cathepsin
monomer
dimer
well
solubl
ecm
membranebound
form
aguda
et
al
henc
differ
substrat
cleav
cathepsin
given
substrat
process
differ
enzym
depend
whether
cathepsin
secret
activ
monom
dimer
scaffold
ecm
constitu
bound
cell
surfac
receptor
complex
alloster
cofactor
import
note
cystein
cathepsin
k
wellstudi
particu
lar
signific
antiosteoporot
drug
target
exampl
highlight
research
requir
understand
enzymat
activ
cathepsin
regul
particular
unexpect
locat
thu
wellaccept
concept
cathepsin
optim
cleav
protein
peptid
substrat
acid
ph
reduc
environ
found
endolysosom
must
broaden
import
cathepsin
activ
investig
condit
cellular
stress
case
withvir
infect
detail
cat
hepsin
belong
oblig
constitu
compart
endocyt
pathway
exert
function
optim
howev
phenomenon
leaki
lysosom
also
known
long
cellular
stress
case
cancer
cell
prolong
drug
treatment
uv
irradi
caus
leaki
endolysosom
membran
matur
cathepsin
may
releas
cytosol
proteolyt
activ
control
differ
mean
endogen
inhibitor
specif
bind
enzym
biochem
properti
cytosol
optim
cathepsinmedi
cleavag
howev
escap
safeguard
measur
instanc
inhibitor
downregul
proteolyt
activ
cathepsin
may
present
cytosol
prolong
time
interv
induc
apoptot
necrot
pyroptot
cascad
result
cell
death
turk
et
al
luke
et
al
turk
turk
ait
fu
rthermor
cytosol
nuclear
cathepsin
may
modul
cell
cycl
progress
goulet
nepveu
brix
et
al
tamhan
et
al
ntermin
truncat
ms
canon
preprocathepsin
translat
eg
altern
transcript
believ
lack
signal
peptid
part
propeptid
mehtani
et
al
zwicki
et
al
et
al
baici
et
al
schill
et
al
tholen
et
al
brix
et
al
therefor
target
entri
er
lumen
follow
secretori
pathway
instead
ntermin
truncat
cathepsin
retain
cytosol
even
fold
properli
acquir
proteolyt
activ
state
unexpect
locat
goulet
nepveu
luke
et
al
reiser
et
al
tedelind
et
al
altern
aberr
form
cathepsin
occur
even
nuclear
matrix
fig
center
bottom
mechan
transport
nuclear
pore
complex
known
endolysosom
enzym
except
aeplegumain
lack
nuclear
local
sequenc
nl
reason
assum
howev
nuclear
cathepsin
well
cytosol
form
involv
process
transcript
factor
core
andor
linker
histon
vitro
experi
reveal
import
role
dna
potenti
scaffold
factor
interfer
serpinmedi
control
cathepsin
activ
environ
mimic
unexpect
cellular
locat
like
nuclear
matrix
ong
et
al
cathepsin
well
known
process
spike
protein
sar
mer
coronavirus
therebi
activ
viral
fusogen
enabl
host
cell
entri
within
endosom
millet
whittak
simmon
et
al
healdsarg
gallagh
thu
treatment
option
prevent
host
cell
infect
sarscov
propos
involv
cystein
cathepsin
l
inhibitor
tong
complex
mechan
proteolyt
activ
fusion
protein
henipavirus
hnv
describ
essenti
prerequisit
infect
pathogen
highli
pathogen
paramyxovirus
wei
maisner
nonfusogen
protein
f
hnv
translat
host
cell
subsequ
transport
along
secretori
pathway
inact
form
plasma
membran
upon
reintern
process
recycl
endosom
cathepsin
b
l
pager
dutch
meulendyk
et
al
vogt
et
al
pager
et
al
diederich
et
al
activ
complex
travel
back
plasma
membran
incorpor
bud
viru
particl
mediat
fusion
infect
cell
neighbor
cell
henc
endosom
cystein
cathepsin
b
l
play
essenti
role
promot
spread
infect
format
syncytia
thu
signific
dif
ferenc
cathepsinmedi
activ
viral
fusion
protein
hnv
occur
late
stage
replic
wherea
sar
mer
coronavirus
activ
upon
viru
entri
host
cell
endosom
cystein
cathepsin
b
l
also
involv
process
envelop
glycoprotein
marburg
ebola
virus
cathepsin
cleavag
enabl
glycoprotein
interact
niemannpick
diseas
type
protein
host
cell
essenti
step
filoviru
entri
hunt
et
al
likewis
endosom
cathepsin
util
nonenvelop
reovirus
host
cell
entri
remov
outer
capsid
protein
cathepsin
viral
protein
expos
fusion
protein
promot
endosom
membran
ruptur
danthi
et
al
viru
infect
may
affect
transcript
regul
cathepsin
gene
lead
disbalanc
cell
function
addit
ntermin
truncat
form
cathepsin
reach
cytosol
fulllength
enzym
due
releas
endolysosom
conceiv
altern
cathepsin
form
may
deriv
alter
gene
may
result
gene
mutat
chromosom
aberr
occur
cancer
cell
due
upregul
translat
altern
transcript
viral
oncogen
may
affect
amplif
cathepsin
gene
moham
sloan
propos
endogen
retrovirus
element
thereof
may
activ
placentaspecif
gene
encod
cystein
cathepsin
mice
rawn
cross
moreov
hivinfect
macrophag
report
upregul
cytosol
cystein
proteas
inhibitor
cystatin
b
stefin
b
cystein
cathepsin
b
believ
trigger
neuron
cell
death
neurocognit
disord
hand
rivera
et
al
similarli
viru
transform
cultur
cell
vitro
known
caus
upregul
secret
socal
major
excret
protein
mep
found
secret
media
transform
fibroblast
identifi
proteolyt
activ
cathepsin
l
mason
et
al
rubin
thu
virus
may
affect
transcript
regul
cathepsin
gene
may
therebi
also
caus
mistraffick
proteas
hepatocellular
carcinoma
caus
infect
hepat
b
c
virus
alter
cathepsin
traffick
also
result
secret
particular
case
virusinduc
liver
cancer
oversecret
cathepsin
complic
defect
function
receptor
cimpr
pathway
normal
act
recaptur
mechan
intern
faulti
excess
secret
cathepsin
see
scharf
braulk
thu
absenc
reintern
cue
cathepsin
may
present
enhanc
amount
cell
surfac
hepatocellular
carcinoma
cell
find
summar
show
anoth
far
rare
consid
scenario
may
like
name
virus
may
interact
cathepsin
present
extracellular
space
eg
cancer
cell
even
enter
host
cell
endocyt
compart
acknowledg
cathepsin
may
well
act
proteolyt
enzym
alreadi
pericellular
space
see
becom
clear
point
virus
constitu
process
principl
extracellular
cathepsin
actual
enter
host
cell
endocytosi
fig
top
center
also
mention
context
extracellular
cathepsin
bmediat
shed
constitu
glycocalyx
endotheli
cell
propos
process
support
infect
virus
caus
hemorrhag
fever
becker
et
al
likewis
cystein
cathepsin
b
l
smediat
shed
ecadherin
import
cellcel
adhes
molecul
suggest
caus
epit
helial
cell
damag
therebi
promot
diseas
progress
patient
viral
infect
grabowska
day
taken
togeth
observ
illustr
differ
mechan
virus
may
upregul
express
stimul
secret
cathepsin
also
suggest
cathepsin
activ
virus
endocytot
compart
also
cell
surfac
final
find
support
concept
cathepsin
contribut
pathogenesi
activ
fusion
capac
virus
also
mechan
promot
cell
tissu
damag
final
chapter
cathepsin
book
virus
end
without
place
special
note
context
therapeut
approach
aim
elimin
virus
host
particular
retrovir
hiv
proteas
import
matur
viru
particl
henc
target
therapeut
moyl
gazzard
cooper
hiv
proteinas
structur
resembl
ubiquit
express
aspart
cathepsin
denot
similar
host
cell
aspart
cathepsin
retrovir
aspart
proteas
case
inhibit
approach
transitionst
inhibitor
therefor
conclus
basic
scienc
research
virologist
clinician
learn
lot
structur
similar
host
cell
cathepsin
viral
proteas
deduc
interact
cell
biologist
virologist
bear
interest
fact
gather
futur
moreov
mani
potenti
therapeut
answer
develop
encount
cathepsin
variou
virus
util
proteas
favor
henc
comment
chapter
meant
support
stimul
futur
discuss
spirit
think
box
like
cathepsin
follow
path
beyond
canon
pathway
opinion
endeavor
worth
undertaken
continu
futur
